Alprostadil associated with low molecular weight heparin to treat limb ischemia caused by SARS-CoV2
| Autor: | Manhanelli Filho,Marcos Antonio Bonacorso, Duarte Júnior,Eliud Garcia, Mariuba,Jamil Victor de Oliveira, Linardi,Fábio, Costa,José Augusto, Gali,Julio Cesar, Yoshida,Winston Bonetti, Gali Filho,Julio Cesar |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: | |
| Zdroj: | Jornal Vascular Brasileiro v.19 2020 Jornal Vascular Brasileiro Sociedade Brasileira de Angiologia e de Cirurgia Vascular (SBACV) instacron:SBACV |
| Popis: | The current coronavirus pandemic has already taken a great toll globally, causing massive morbidity and mortality. One of its severe forms is a thrombophilic state that can damage several systems. This article reports the case of 60-year-old female patient who presented with mild flu symptoms, which turned out to be a SARS-CoV2 infection, and ended up developing arterial thrombosis with limb ischemia in a private care hospital in Sorocaba, São Paulo, Brazil. Considering this progression, we decided to intervene with low molecular weight heparin and Alprostadil, achieving a good clinical outcome. Our description aims to identify key points and clinical signs that offer evidence of the therapeutic window and a treatment option for coagulatory presentations of COVID-19. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|